Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-003876

Chairman & CEO sold 19,875 shares at an average $77.61 ($1,542,513)

  • Chairman & CEO acquired 29,375 shares (option exercise)
  • Chairman & CEO gave 105,905 shares (gift)
  • Chairman & CEO gave 105,905 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

MUSSALLEM MICHAEL A · Chairman & CEO

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-15 Gift : show line 1 in the form −96,405 60,947.82 D
2023-03-14 Exercise or conversion : show line 2 in the form +29,375 $35.20 $1,033,903 90,322.82 D
2023-03-14 Sale : show line 3 in the form −9,175 $77.32 $709,411 81,147.82 D
2023-03-14 Gift : show line 4 in the form −9,500 71,647.82 D
2023-03-14 Sale : show line 5 in the form −10,700 $77.86 $833,102 60,947.82 D
2023-02-15 Gift : show line 6 in the form +96,405 3,588,422 I
2023-03-14 Gift : show line 7 in the form +9,500 3,597,922 I
Open-market sales · 19,875 sh · avg $77.61 · $1,542,513

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-03-14 Exercise or conversion : show line 8 in the form Employee Stock Option (Right to Acquire) −29,375 $35.20 2023-05-11 29,375 58,750 D
Loading xslF345X03/doc4.xml…